EyePoint Pharmaceuticals, Inc. (EYPT) financial statements and ratios from SEC XBRL: revenue $31.37M (TTM), net margin -739.4%, revenue growth -90.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $31.37M |
| Net Margin | -739.4% |
| Revenue Growth (YoY) | -90.5% |
| EPS Growth (YoY) | 28.2% |
| FCF Growth (YoY) | -0.4% |
| Price / Book | 2.80 |
| Price / Sales | 167.29 |
| FCF Yield | -94.3% |
| Altman Z-Score | -0.73 (distress) |
| Sector P/E (Technology) | 33.9 |
EYPT overview · EYPT earnings · EYPT KPIs · EYPT investor relations · EYPT ownership · EYPT peers · EYPT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.